IFN-γ exerts its effects by binding to specific receptors on the surface of target cells. Upon binding, a signal transduction cascade is initiated, leading to the activation of genes involved in immune responses. This cytokine enhances the ability of immune cells to recognize and destroy cancer cells, and it also inhibits angiogenesis, which is the formation of new blood vessels that tumors need to grow.
